Program Committee
-
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan -
Rie Matsui, RPH Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan -
Katsuhiko Ichimaru Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Kazuhiko Ishida, MSC, RPH Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Tomoyuki Kakizume, PHD
Daiichi Sankyo Co., Ltd., Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Yukihiro Matsuda, MSC Director of Project Management
Linical Japan, Japan -
Yukiko Nishimura, PHD, MSC Director
Advocacy Service for Rare and Intractable Diseases, Japan -
Mika Ogasawara Data Quality Lead, Biometrics and Data Management
Pfizer R&D Japan G.K., Japan -
Takashi Sato, MSC, PMP
PM Orchestra Takashi Sato, Japan -
Katsuhiko Sawada, MPHARM Director, Research and Development Dept.
Otsuka Medical Devices Co.Ltd., Japan -
Kazuyuki Suzuki, MSC Feasibility Manager,Devlopment SSO protfolio
Novartis Pharma K.K., Japan -
Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan -
Nariaki Uemura Development Project Management, Development
Astellas Pharma Inc., Japan -
Tadashi Urashima, PHD Performance and Digital Analytics Lead, Japan Development
GlaxoSmithKline K.K., Japan -
Koichiro Yuji, MD, PHD, FACP Project Associate Professor, The Institute of Medical Science
Japan -
Keiichi Inaizumi, MSC Clinical Study Innovation Lead, Clinical Project Management Group
Pfizer R&D Japan, Japan -
Junichi Nishino, MSC, RPH Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Hironobu Saito, PHD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PHD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Atsushi Tsukamoto, PHD, MSC Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
Have an account?